Metronidazole Braun

Metronidazole, the active ingredient in Metronidazole Braun, is a nitroimidazole presented as an injection for intravenous use. It treats anaerobic bacterial infections and related conditions in both adult and pediatric patients as prescribed by a healthcare professional, including bacterial vaginosis, trichomoniasis, amebic liver abscess, and Clostridioides difficile infection.

GNH USA supplies Metronidazole Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, tertiary care centers, and specialty clinics worldwide. The company adheres to stringent quality standards and provides regulatory support for global distribution.

Metronidazole Braun is used to treat infections caused by anaerobic bacteria and certain protozoa. - Anaerobic bacterial infections: effective against a broad range of anaerobic organisms, reducing infection severity. - Bacterial vaginosis: restores normal vaginal flora by eliminating pathogenic anaerobes. - Trichomoniasis: eradicates the protozoan parasite Trichomonas vaginalis. - Amebic liver abscess: targets Entamoeba histolytica to resolve hepatic lesions. - Clostridioides difficile infection: suppresses toxin‑producing C. difficile strains in the colon.

Common side effects are typically mild and transient.

Common Side Effects: - Nausea - Metallic taste - Headache - Dizziness - Diarrhea - Abdominal pain

Serious or Rare Side Effects: - Seizures - Peripheral neuropathy - Severe allergic reactions (anaphylaxis) - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Severe neutropenia or leukopenia - Hepatic dysfunction

Metronidazole Braun should be used with caution in specific clinical situations. - Renal impairment: assess renal function and consider dose adjustment. - Hepatic dysfunction: monitor liver enzymes during therapy. - Alcohol consumption: avoid alcohol to prevent a disulfiram‑like reaction. - Pregnancy: prescribe only when benefits outweigh potential risks. - Concomitant warfarin therapy: monitor INR closely for increased anticoagulant effect. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Metronidazole Braun may interact with several medicines; some require avoidance while others need monitoring.

Major Interactions (Avoid): - Alcohol: can cause severe disulfiram‑like reaction. - Warfarin: may increase anticoagulant effect, requiring INR monitoring. - Lithium: risk of elevated lithium levels.

Moderate Interactions (Monitor Closely): - Cimetidine: may raise metronidazole plasma concentrations. - Phenobarbital: may reduce metronidazole efficacy. - Phenytoin: may decrease therapeutic levels of metronidazole.